A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorder.
By C. Bowden, J. Calabrese, G. Sachs, L. Yatham, Shaheen Asghar, M. Hompland, Paul Montgomery, N. Earl, T. Smoot, J. Deveaugh-Geiss. Archives of General Psychiatry, 2003
640 citations recorded by the source corpus.
Subfields: Clinical Psychology, Psychiatry and Mental health
View Paper: https://www.semanticscholar.org/paper/4ccb329e9fb66c0347a2d9c10caa30475f66504b
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Clinical Psychology
Citations in the corpus
- Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders (2015, background): “Lamotrigine has greater efficacy in the prevention of depressive relapse but relatively modest impact on risk of manic relapse (Level I) (Bowden et al., 2003; Calabrese et al., 2003; Goodwin et al., 2004; Licht et al., 2010; Van der Loos et al., 2011).”